Expertise in
6
conditions

Saskia K. Klein

Martini Ziekenhuis
Groningen, GR, NL 
Expertise in
6
conditions
Martini Ziekenhuis
Groningen, GR, NL 

Overview

Saskia Klein practices practicing medicine in Groningen, Netherlands.

Ms. Klein is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Systemic Mastocytosis, Myelodysplastic Syndrome (MDS), Leukemia, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 65 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Martini Ziekenhuis
Groningen, GR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pom/Dex (Pomalidomide plus Low Dose Dexamethasone)
Study Phase: Phase 3

65 Total Publications

Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
Journal: Experimental hematology & oncology
Published: June 21, 2026

Frequently Asked Questions about Saskia K. Klein

Is Saskia K. Klein a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Saskia K. Klein is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Saskia K. Klein participate in research or clinical trials?

Yes. Saskia K. Klein has published 65 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Saskia K. Klein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Klein's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile